THC.CN - THC Biomed Intl Ltd.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD

THC Biomed Intl Ltd.

1340 St. Paul Street
Kelowna, BC V1Y 2E1
Canada
250-870-2512
http://www.thcbiomed.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees25

Key Executives

NameTitlePayExercisedYear Born
Mr. John MillerChief Exec. Officer, Pres and Director62.4kN/AN/A
Jung Chun HeeCo-Founder, CFO & Director62.4kN/AN/A
Mr. Damien ReynoldsChief Capital Markets OfficerN/AN/AN/A
Ms. Dianne Marie SzigetyCorp. Sec.N/AN/A1954
Amounts are as of December 31, 2016 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

THC Biomed Intl Ltd. produces and sells medical marijuana in Canada. It also conducts research and development of the products and services related to cannabis for medical purposes. The company was founded in 2012 and is headquartered in Kelowna, Canada.

Corporate Governance

THC Biomed Intl Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.